The therapeutic apheresis market is estimated at USD 3.0 billion in 2026, is projected to reach USD 4.4 billion by 2036 and is forecast to register a 3.9% CAGR between 2026 and 2036. In 2026, therapeutic plasma exchange holds 41.3% of procedure type demand and hospitals represent 47.8% of end user sales.